Vemircopan (ALXN2050) Monotherapy in Paroxysmal Nocturnal Hemoglobinuria: Interim Data from a Phase 2 Open-Label Proof-of-Concept Study

Authors
Category Primary study
JournalBlood
Year 2022
This article has no abstract
Epistemonikos ID: a6690b4955004f610a2c47401935ce708cbf95fb
First added on: Feb 16, 2025